Author | Robert J. Kreitman, MD | OncLive

Author | Robert J. Kreitman, MD

Articles

Dr. Kreitman on Ongoing Research With Moxetumomab Pasudotox in Hairy Cell Leukemia

April 17, 2020

Video

Robert J. Kreitman, MD, senior investigator and head of the Clinical Immunotherapy Section in the Laboratory of Molecular Biology at the National Cancer Institute, discusses ongoing research with moxetumomab pasudotox-tdfk (Lumoxiti) in patients with hairy cell leukemia (HCL).

Dr. Kreitman on the Use of Moxetumomab Pasudotox in Hairy Cell Leukemia

January 31, 2020

Video

Robert J. Kreitman, MD, senior investigator and head of the Clinical Immunotherapy Section in the Laboratory of Molecular Biology at the National Cancer Institute, discusses the use of moxetumomab pasudotox-tdfk (Lumoxiti) in heavily pretreated patients with relapsed/refractory hairy cell leukemia (HCL).

Dr. Kreitman on MRD-Negative CRs With Moxetumomab Pasudotox in Hairy Cell Leukemia

October 25, 2019

Video

Robert J. Kreitman, MD, discusses the association between minimal residual disease-negativity and complete remission durations in patients with hairy cell leukemia treated with moxetumomab pasudotox.

Dr. Kreitman on the Prognosis of Hairy Cell Leukemia

September 25, 2018

Video

Robert J. Kreitman, MD, chief, Clinical Immunotherapy Section, Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, discusses the prognosis for patients diagnosed with hairy cell leukemia.

x